Larry E. Kun

32.0k total citations · 3 hit papers
373 papers, 20.5k citations indexed

About

Larry E. Kun is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Larry E. Kun has authored 373 papers receiving a total of 20.5k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Genetics, 128 papers in Neurology and 127 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Larry E. Kun's work include Glioma Diagnosis and Treatment (190 papers), Neuroblastoma Research and Treatments (93 papers) and Brain Metastases and Treatment (50 papers). Larry E. Kun is often cited by papers focused on Glioma Diagnosis and Treatment (190 papers), Neuroblastoma Research and Treatments (93 papers) and Brain Metastases and Treatment (50 papers). Larry E. Kun collaborates with scholars based in United States, Canada and Australia. Larry E. Kun's co-authors include Raymond K. Mulhern, Thomas E. Merchant, Amar Gajjar, Robert A. Sanford, Wilburn E. Reddick, Henry S. Friedman, James M. Boyett, Peter C. Burger, Xiaoping Xiong and Richard L. Heideman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Larry E. Kun

370 papers receiving 20.0k citations

Hit Papers

Late neurocognitive sequelae in survivors of brain tumour... 1993 2026 2004 2015 2004 1993 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry E. Kun United States 77 10.2k 6.0k 5.8k 4.7k 4.0k 373 20.5k
Roger J. Packer United States 91 15.0k 1.5× 5.6k 0.9× 10.1k 1.8× 8.1k 1.7× 4.9k 1.2× 465 27.6k
Éric Bouffet Canada 69 10.3k 1.0× 3.4k 0.6× 5.9k 1.0× 5.0k 1.1× 2.5k 0.6× 557 17.6k
Amar Gajjar United States 78 13.3k 1.3× 4.7k 0.8× 5.6k 1.0× 8.9k 1.9× 4.2k 1.1× 429 23.5k
James M. Boyett United States 70 7.8k 0.8× 2.9k 0.5× 4.2k 0.7× 4.4k 0.9× 2.8k 0.7× 232 15.2k
Thomas E. Merchant United States 71 9.1k 0.9× 6.5k 1.1× 3.8k 0.7× 2.7k 0.6× 3.1k 0.8× 444 17.9k
Jonathan L. Finlay United States 63 9.0k 0.9× 3.2k 0.5× 5.0k 0.9× 4.2k 0.9× 1.2k 0.3× 326 13.6k
Nancy J. Tarbell United States 73 4.6k 0.4× 5.7k 0.9× 3.3k 0.6× 1.4k 0.3× 2.0k 0.5× 219 14.3k
Ian F. Pollack United States 71 7.9k 0.8× 2.2k 0.4× 4.6k 0.8× 5.1k 1.1× 1.0k 0.3× 381 16.6k
Richard Sposto United States 67 4.2k 0.4× 2.0k 0.3× 3.9k 0.7× 3.3k 0.7× 1.8k 0.5× 282 13.4k
Anna T. Meadows United States 82 2.5k 0.2× 4.0k 0.7× 3.0k 0.5× 2.7k 0.6× 10.4k 2.6× 229 22.0k

Countries citing papers authored by Larry E. Kun

Since Specialization
Citations

This map shows the geographic impact of Larry E. Kun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Kun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Kun more than expected).

Fields of papers citing papers by Larry E. Kun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Kun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Kun. The network helps show where Larry E. Kun may publish in the future.

Co-authorship network of co-authors of Larry E. Kun

This figure shows the co-authorship network connecting the top 25 collaborators of Larry E. Kun. A scholar is included among the top collaborators of Larry E. Kun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry E. Kun. Larry E. Kun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Lindsey M., Maryam Fouladi, James M. Olson, et al.. (2015). Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Child s Nervous System. 31(8). 1283–1289. 41 indexed citations
2.
Gajjar, Amar, Clinton F. Stewart, David W. Ellison, et al.. (2013). Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study. Clinical Cancer Research. 19(22). 6305–6312. 164 indexed citations
3.
Tarbell, Nancy J., Henry S. Friedman, William R. Polkinghorn, et al.. (2013). High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031). Journal of Clinical Oncology. 31(23). 2936–2941. 108 indexed citations
4.
Krull, Kevin R., Nan Zhang, Aimee Santucci, et al.. (2013). Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. Blood. 122(4). 550–553. 37 indexed citations
5.
Ashley, David M., Thomas E. Merchant, Douglas Strother, et al.. (2012). Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934. Journal of Clinical Oncology. 30(26). 3181–3186. 67 indexed citations
6.
Prabhu, Sanjay P., Sridhar Vajapeyam, Mark W. Kieran, et al.. (2010). DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy. Child s Nervous System. 27(1). 11–18. 36 indexed citations
7.
Fouladi, Maryam, Clinton F. Stewart, Susan M. Blaney, et al.. (2010). Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study. Journal of Clinical Oncology. 28(27). 4221–4227. 62 indexed citations
8.
Fouladi, Maryam, S. Gururangan, Albert Moghrabi, et al.. (2009). Carboplatin‐based primary chemotherapy for infants and young children with CNS tumors. Cancer. 115(14). 3243–3253. 19 indexed citations
9.
Donaldson, Sarah S., Michael P. Link, Howard J. Weinstein, et al.. (2007). Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease. Journal of Clinical Oncology. 25(3). 332–337. 86 indexed citations
10.
Madewell, John E., Robert R. Hattery, Stephen Thomas, et al.. (2005). American Board of Radiology. Academic Radiology. 12(1). 104–115. 10 indexed citations
11.
Packer, Roger J., Jaclyn A. Biegel, Susan M. Blaney, et al.. (2002). Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: Report on Workshop. Journal of Pediatric Hematology/Oncology. 24(5). 337–342. 164 indexed citations
12.
Mulne, Arlynn F., Jonathan M. Ducore, Roy D. Elterman, et al.. (2000). Oral Methotrexate for Recurrent Brain Tumors in Children: A Pediatric Oncology Group Study. ˜The œAmerican journal of pediatric hematology/oncology. 22(1). 41–44. 16 indexed citations
13.
Burger, Peter C., Tarık Tihan, Henry S. Friedman, et al.. (1998). Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: A Highly Malignant Tumor of Infancy and Childhood Frequently Mistaken for Medulloblastoma. The American Journal of Surgical Pathology. 22(9). 1083–1092. 315 indexed citations
14.
Sanford, Robert A., Larry E. Kun, Richard L. Heideman, & Amar Gajjar. (1997). Cerebellar Pontine Angle Ependymoma in Infants. Pediatric Neurosurgery. 27(2). 84–91. 10 indexed citations
15.
Freeman, Carolyn, Pierre Bourgouin, Robert A. Sanford, et al.. (1996). Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy: Clinical characteristics and treatment related toxicities. Cancer. 77(3). 555–562. 3 indexed citations
16.
Regine, William F., James Fontanesi, Parvesh Kumar, et al.. (1995). A phase II trial evaluation selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics. 31(4). 799–805. 11 indexed citations
17.
Regine, William F., James Fontanesi, Parvesh Kumar, et al.. (1995). Local tumor control in rhabdomyosarcoma following low-dose irradiation: Comparison of group II and select group III patients. International Journal of Radiation Oncology*Biology*Physics. 31(3). 485–491. 29 indexed citations
18.
Duffner, Patricia K., Peter C. Burger, Michael E. Cohen, et al.. (1994). Desmoplastic Infantile Gangliogliomas. Neurosurgery. 34(4). 583–589. 56 indexed citations
19.
Shuster, Jonathan J., Nancy B. McWilliams, Robert P. Castleberry, et al.. (1992). Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study. American Journal of Clinical Oncology. 15(4). 295–303. 57 indexed citations
20.
Thompson, Elizabeth, Judith A. Wilimas, Laura C. Bowman, et al.. (1990). Myeloid neoplasia in children treated for solid tumours. The Lancet. 336(8712). 417–421. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026